Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Investment Management, Inc. | 3,989,830 6.900% | 3,989,830 (New Position) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Associates, Inc. | 10,869,560 2.500% | 7,159,719 (+192.99%) | Filing History |
| 2024-02-14 09:17 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 3,755,555 6.500% | 655,555 (+21.15%) | Filing History |
| 2024-02-13 11:57 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,994,785 6.900% | 350,830 (+9.63%) | Filing History |
| 2024-02-12 06:12 am Sale | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | Artisan Partners Asset Management Inc. | 5,749,227 10.000% | -1,171,129 (-16.92%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,114,369 9.067% | -114,701 (-2.19%) | Filing History |
| 2024-02-08 10:03 am Purchase | 2023-12-29 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 3,248,293 5.770% | 172,281 (+5.60%) | Filing History |
| 2024-02-02 1:18 pm Purchase | 2023-12-29 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,030,634 7.050% | 872,466 (+27.63%) | Filing History |
| 2023-04-10 5:00 pm Purchase | 2023-04-06 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 9,967,172 17.400% | 3,009,993 (+43.26%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 6,957,179 12.200% | -610,721 (-8.07%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | Baker Bros. Advisors LP | 4,954,855 8.700% | 413,251 (+9.10%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | T. Rowe Price Associates, Inc. | 3,709,841 6.500% | -1,051,352 (-22.08%) | Filing History |
| 2023-02-14 09:33 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 3,100,000 5.400% | 3,100,000 (New Position) | Filing History |
| 2023-02-10 10:01 am Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | JANUS HENDERSON GROUP PLC JHG | 3,643,955 6.400% | 423,990 (+13.17%) | Filing History |
| 2023-02-10 09:11 am Sale | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | Artisan Partners Asset Management Inc. | 6,920,356 12.100% | -1,020,078 (-12.85%) | Filing History |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Ascendis Pharma A/S ASND | FMR LLC | 5,229,070 9.271% | -126,873 (-2.37%) | Filing History |
| 2023-02-06 2:36 pm Sale | 2022-12-30 | 13G | Ascendis Pharma A/S ASND | Wellington Management Group LLP | 3,076,012 5.400% | -992,464 (-24.39%) | Filing History |
| 2023-02-01 7:36 pm Purchase | 2022-12-30 | 13G | Ascendis Pharma A/S ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 3,158,168 5.540% | 3,158,168 (New Position) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | Baker Bros. Advisors LP | 4,541,604 8.000% | 1,001,334 (+28.28%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | RA Capital Management, L.P. | 7,567,900 13.300% | 1,702,562 (+29.03%) | Filing History |